Mechanisms of antimicrobial peptide resistance in gram-negative bacteria

Antibiotics

Volumn 4, Issue 1, 2014, Pages 18-41

  Band, Victor I ^a,b   Weiss, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

AMP; Antibiotic resistance; Antimicrobial peptide; CAMP; Gram negative

Indexed keywords

AMINOSUGAR; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIUM LIPOPOLYSACCHARIDE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; LIPID A; O ANTIGEN; PAGP PROTEIN; PATTERN RECOGNITION RECEPTOR; PHOP REGULATORY PROTEIN; PHOSPHOLIPID; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; REGULATOR PROTEIN; SLYA REGULATORY PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CAPSULE; BACTERIAL EFFLUX PUMP; BACTERIAL GENE; BACTERIAL SURVIVAL; BACTERIUM MUTANT; BINDING AFFINITY; BIOFILM; BORDETELLA; BRUCELLA ABORTUS; BURKHOLDERIA CENOCEPACIA; ENZYMATIC DEGRADATION; FRANCISELLA NOVICIDA; GRAM NEGATIVE BACTERIUM; HYDROPHOBICITY; LEGIONELLA; MEMBRANE BIOLOGY; MEMBRANE TRANSPORT; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM; REVIEW; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SIAC GENE; SIAD GENE; VIBRIO CHOLERAE; YERSINIA ENTEROCOLITICA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 85019777142     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics4010018     Document Type: Review

References (129)

1. UNMC Department of Pathology and Microbiology. The antimicrobial peptide database. 2014. Available online: http://aps.unmc.edu/AP/main.php (accessed on 2 July 2014).
2. Nakatsuji, T.; Gallo, R.L. Antimicrobial peptides: Old molecules with new ideas. J. Invest. Dermatol. 2012, 132, 887–895
3. Wimley, W.C. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem. Biol. 2010, 5, 905–917
4. Nizet, V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr. Issues Mol. Biol. 2006, 8, 11–26
5. Zavascki, A.P.; Goldani, L.Z.; Li, J.; Nation, R.L. Polymyxin b for the treatment of multidrugresistant pathogens: A critical review. J. Antimicrob. Chemother. 2007, 60, 1206–1215
6. Biswas, S.; Brunel, J.M.; Dubus, J.C.; Reynaud-Gaubert, M.; Rolain, J.M. Colistin: An update on the antibiotic of the 21st century. Expert. Rev. Anti. Infect. Ther. 2012, 10, 917–934
7. Moskowitz, S.M.; Ernst, R.K.; Miller, S.I. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 2004, 186, 575–579
8. Gunn, J.S.; Lim, K.B.; Krueger, J.; Kim, K.; Guo, L.; Hackett, M.; Miller, S.I. PmrA-pmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 1998, 27, 1171–1182
9. Loutet, S.A.; Valvano, M.A. Extreme antimicrobial peptide and polymyxin B resistance in the genus burkholderia. Front. Microbiol. 2011, 2, e159
10. Llewellyn, A.C.; Zhao, J.; Song, F.; Parvathareddy, J.; Xu, Q.; Napier, B.A.; Laroui, H.; Merlin, D.; Bina, J.E.; Cotter, P.A.; et al. NaxD is a deacetylase required for lipid A modification and Francisella pathogenesis. Mol. Microbiol. 2012, 86, 611–627
11. Kanistanon, D.; Hajjar, A.M.; Pelletier, M.R.; Gallagher, L.A.; Kalhorn, T.; Shaffer, S.A.; Goodlett, D.R.; Rohmer, L.; Brittnacher, M.J.; Skerrett, S.J.; et al. A francisella mutant in lipid a carbohydrate modification elicits protective immunity. PLoS Pathog. 2008, 4, e24
12. Shah, N.R.; Hancock, R.E.; Fernandez, R.C. Bordetella pertussis lipid A glucosamine modification confers resistance to cationic antimicrobial peptides and increases resistance to outer membrane perturbation. Antimicrob. Agents Chemother. 2014, 58, 4931–4934
13. Hankins, J.V.; Madsen, J.A.; Giles, D.K.; Brodbelt, J.S.; Trent, M.S. Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in gram-positive and gram-negative bacteria. Proc. Natl. Acad. Sci. USA 2012, 109, 8722–8727
14. Harris, J.B.; LaRocque, R.C.; Qadri, F.; Ryan, E.T.; Calderwood, S.B. Cholera. Lancet 2012, 379, 2466–2476
15. Lewis, L.A.; Choudhury, B.; Balthazar, J.T.; Martin, L.E.; Ram, S.; Rice, P.A.; Stephens, D.S.; Carlson, R.; Shafer, W.M. Phosphoethanolamine substitution of lipid a and resistance of neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect. Immun. 2009, 77, 1112–1120
16. Lewis, L.A.; Shafer, W.M.; Dutta Ray, T.; Ram, S.; Rice, P.A. Phosphoethanolamine residues on the lipid a moiety of neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect. Immun. 2013, 81, 33–42
17. Pelletier, M.R.; Casella, L.G.; Jones, J.W.; Adams, M.D.; Zurawski, D.V.; Hazlett, K.R.; Doi, Y.; Ernst, R.K. Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 2013, 57, 4831–4840
18. Lee, H.; Hsu, F.F.; Turk, J.; Groisman, E.A. The pmra-regulated pmrc gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 2004, 186, 4124–4133
19. Wang, X.; Ribeiro, A.A.; Guan, Z.; Abraham, S.N.; Raetz, C.R. Attenuated virulence of a Francisella mutant lacking the lipid a 4'-phosphatase. Proc. Natl. Acad. Sci. USA 2007, 104, 4136–4141
20. Vinogradov, E.; Perry, M.B.; Conlan, J.W. Structural analysis of francisella tularensis lipopolysaccharide. Eur. J. Biochem. 2002, 269, 6112–6118
21. Ingram, B.O.; Masoudi, A.; Raetz, C.R. Escherichia coli mutants that synthesize dephosphorylated lipid a molecules. Biochemistry 2010, 49, 8325–8337
22. Kumada, H.; Haishima, Y.; Umemoto, T.; Tanamoto, K. Structural study on the free lipid a isolated from lipopolysaccharide of porphyromonas gingivalis. J. Bacteriol. 1995, 177, 2098–2106
23. Weintraub, A.; Zähringer, U.; Wollenweber, H.W.; Seydel, U.; Rietschel, E.T. Structural characterization of the lipid a component of bacteroides fragilis strain nctc 9343 lipopolysaccharide. Eur. J. Biochem. 1989, 183, 425–431
24. Tran, A.X.; Whittimore, J.D.; Wyrick, P.B.; McGrath, S.C.; Cotter, R.J.; Trent, M.S. The lipid A 1-phosphatase of helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin. J. Bacteriol. 2006, 188, 4531–4541
25. Needham, B.D.; Trent, M.S. Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis. Nat. Rev. Microbiol. 2013, 11, 467–481
26. Guo, L.; Lim, K.B.; Poduje, C.M.; Daniel, M.; Gunn, J.S.; Hackett, M.; Miller, S.I. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998, 95, 189–198
27. Darveau, R.P.; Blake, J.; Seachord, C.L.; Cosand, W.L.; Cunningham, M.D.; Cassiano-Clough, L.; Maloney, G. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J. Clin. Invest. 1992, 90, 447–455
28. Fields, P.I.; Groisman, E.A.; Heffron, F. A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science 1989, 243, 1059–1062
29. Miller, S.I.; Kukral, A.M.; Mekalanos, J.J. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA 1989, 86, 5054–5058
30. Bader, M.W.; Sanowar, S.; Daley, M.E.; Schneider, A.R.; Cho, U.; Xu, W.; Klevit, R.E.; le Moual, H.; Miller, S.I. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 2005, 122, 461–472
31. Gunn, J.S.; Miller, S.I. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol. 1996, 178, 6857–6864
32. Guo, L.; Lim, K.B.; Gunn, J.S.; Bainbridge, B.; Darveau, R.P.; Hackett, M.; Miller, S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276, 250–253
33. McPhee, J.B.; Lewenza, S.; Hancock, R.E. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 2003, 50, 205–217
34. Lin, Q.Y.; Tsai, Y.L.; Liu, M.C.; Lin, W.C.; Hsueh, P.R.; Liaw, S.J. Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance. Antimicrob. Agents Chemother. 2014, 58, 5181–5190
35. Adams, M.D.; Nickel, G.C.; Bajaksouzian, S.; Lavender, H.; Murthy, A.R.; Jacobs, M.R.; Bonomo, R.A. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 2009, 53, 3628–3634
36. Allen, C.A.; Adams, L.G.; Ficht, T.A. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect. Immun. 1998, 66, 1008–1016
37. Loutet, S.A.; Flannagan, R.S.; Kooi, C.; Sokol, P.A.; Valvano, M.A. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J. Bacteriol. 2006, 188, 2073–2080
38. Robey, M.; O’Connell, W.; Cianciotto, N.P. Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect. Immun. 2001, 69, 4276–4286
39. Jerse, A.E.; Sharma, N.D.; Simms, A.N.; Crow, E.T.; Snyder, L.A.; Shafer, W.M. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 2003, 71, 5576–5582
40. Walker, K.E.; Moghaddame-Jafari, S.; Lockatell, C.V.; Johnson, D.; Belas, R. ZapA, the IgA-degrading metalloprotease of Proteus mirabilis, is a virulence factor expressed specifically in swarmer cells. Mol. Microbiol. 1999, 32, 825–836
41. Padilla, E.; Llobet, E.; Doménech-Sánchez, A.; Martínez-Martínez, L.; Bengoechea, J.A.; Albertí, S. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 2010, 54, 177–183
42. Park, P.W.; Pier, G.B.; Preston, M.J.; Goldberger, O.; Fitzgerald, M.L.; Bernfield, M. Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa. J. Biol. Chem. 2000, 275, 3057–3064
43. Park, P.W.; Pier, G.B.; Hinkes, M.T.; Bernfield, M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 2001, 411, 98–102
44. Haynes, A.; Ruda, F.; Oliver, J.; Hamood, A.N.; Griswold, J.A.; Park, P.W.; Rumbaugh, K.P. Syndecan 1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect. Immun. 2005, 73, 7914–7921
45. Groisman, E.A.; Parra-Lopez, C.; Salcedo, M.; Lipps, C.J.; Heffron, F. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc. Natl. Acad. Sci. USA 1992, 89, 11939–11943
46. Strandberg, K.L.; Richards, S.M.; Tamayo, R.; Reeves, L.T.; Gunn, J.S. An altered immune response, but not individual cationic antimicrobial peptides, is associated with the oral attenuation of Ara4N-deficient Salmonella enterica serovar typhimurium in mice. PLoS ONE 2012, 7, e49588
47. Gunn, J.S.; Ryan, S.S.; van Velkinburgh, J.C.; Ernst, R.K.; Miller, S.I. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar typhimurium. Infect. Immun. 2000, 68, 6139–6146
48. Shi, Y.; Latifi, T.; Cromie, M.J.; Groisman, E.A. Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins. J. Biol. Chem. 2004, 279, 38618–38625
49. Libby, S.J.; Goebel, W.; Ludwig, A.; Buchmeier, N.; Bowe, F.; Fang, F.C.; Guiney, D.G.; Songer, J.G.; Heffron, F. A cytolysin encoded by Salmonella is required for survival within macrophages. Proc. Natl. Acad. Sci. USA 1994, 91, 489–493
50. Hohmann, E.L.; Oletta, C.A.; Killeen, K.P.; Miller, S.I. PhoP/PhoQ-deleted Salmonella typhi (ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 1996, 173, 1408–1414
51. Bengoechea, J.A.; Díaz, R.; Moriyón, I. Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect. Immun. 1996, 64, 4891–4899
52. Raetz, C.R.; Reynolds, C.M.; Trent, M.S.; Bishop, R.E. Lipid A modification systems in gramnegative bacteria. Annu. Rev. Biochem. 2007, 76, 295–329
53. Dalebroux, Z.D.; Matamouros, S.; Whittington, D.; Bishop, R.E.; Miller, S.I. PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane. Proc. Natl. Acad. Sci. USA 2014, 111, 1963–1968
54. Cox, E.; Michalak, A.; Pagentine, S.; Seaton, P.; Pokorny, A. Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides. Biochim. Biophys. Acta 2014, 1838, 2198–2204
55. Sohlenkamp, C.; Galindo-Lagunas, K.A.; Guan, Z.; Vinuesa, P.; Robinson, S.; Thomas-Oates, J.; Raetz, C.R.; Geiger, O. The lipid lysyl-phosphatidylglycerol is present in membranes of Rhizobium tropici CIAT899 and confers increased resistance to polymyxin B under acidic growth conditions. Mol. Plant Microbe Interact. 2007, 20, 1421–1430
56. Jones, D.E.; Smith, J.D. Phospholipids of the differentiating bacterium Caulobacter crescentus. Can. J. Biochem. 1979, 57, 424–428
57. Yokum, T.S.; Hammer, R.P.; McLaughlin, M.L.; Elzer, P.H. Peptides with indirect in vivo activity against an intracellular pathogen: Selective lysis of infected macrophages. J. Pept. Res. 2002, 59, 9–17
58. Dorschner, R.A.; Lopez-Garcia, B.; Peschel, A.; Kraus, D.; Morikawa, K.; Nizet, V.; Gallo, R.L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides. FASEB J. 2006, 20, 35–42
59. Willis, L.M.; Whitfield, C. Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by abc transporter-dependent pathways. Carbohydr. Res. 2013, 378, 35–44
60. Campos, M.A.; Vargas, M.A.; Regueiro, V.; Llompart, C.M.; Albertí, S.; Bengoechea, J.A. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect. Immun. 2004, 72, 7107–7114
61. Cortés, G.; Borrell, N.; de Astorza, B.; Gómez, C.; Sauleda, J.; Albertí, S. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide o side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 2002, 70, 2583–2590
62. Jones, A.; Geörg, M.; Maudsdotter, L.; Jonsson, A.B. Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J. Bacteriol. 2009, 191, 3861–3868
63. Llobet, E.; Tomás, J.M.; Bengoechea, J.A. Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 2008, 154, 3877–3886
64. Costerton, J.W.; Stewart, P.S.; Greenberg, E.P. Bacterial biofilms: A common cause of persistent infections. Science 1999, 284, 1318–1322
65. Jolivet-Gougeon, A.; Bonnaure-Mallet, M. Biofilms as a mechanism of bacterial resistance. Drug Discov. Today Technol. 2014, 11, 49–56
66. Wimpenny, J.; Manz, W.; Szewzyk, U. Heterogeneity in biofilms. FEMS Microbiol. Rev. 2000, 24, 661–671
67. Nickel, J.C.; Ruseska, I.; Wright, J.B.; Costerton, J.W. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 1985, 27, 619–624
68. Hentzer, M.; Teitzel, G.M.; Balzer, G.J.; Heydorn, A.; Molin, S.; Givskov, M.; Parsek, M.R. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol. 2001, 183, 5395–5401
69. Folkesson, A.; Haagensen, J.A.; Zampaloni, C.; Sternberg, C.; Molin, S. Biofilm induced tolerance towards antimicrobial peptides. PLoS ONE 2008, 3, e1891
70. Chan, C.; Burrows, L.L.; Deber, C.M. Helix induction in antimicrobial peptides by alginate in biofilms. J. Biol. Chem. 2004, 279, 38749–38754
71. Chan, C.; Burrows, L.L.; Deber, C.M. Alginate as an auxiliary bacterial membrane: Binding of membrane-active peptides by polysaccharides. J. Pept. Res. 2005, 65, 343–351
72. Benincasa, M.; Mattiuzzo, M.; Herasimenka, Y.; Cescutti, P.; Rizzo, R.; Gennaro, R. Activity of antimicrobial peptides in the presence of polysaccharides produced by pulmonary pathogens. J. Pept. Sci. 2009, 15, 595–600
73. Mulcahy, H.; Charron-Mazenod, L.; Lewenza, S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 2008, 4, e1000213
74. Johnson, L.; Horsman, S.R.; Charron-Mazenod, L.; Turnbull, A.L.; Mulcahy, H.; Surette, M.G.; Lewenza, S. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol. 2013, 13, e115
75. Gooderham, W.J.; Bains, M.; McPhee, J.B.; Wiegand, I.; Hancock, R.E. Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa. J. Bacteriol. 2008, 190, 5624–5634
76. Pamp, S.J.; Gjermansen, M.; Johansen, H.K.; Tolker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol. 2008, 68, 223–240
77. Poole, K. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 2007, 39, 162–176
78. Piddock, L.J. Multidrug-resistance efflux pumps—Not just for resistance. Nat. Rev. Microbiol. 2006, 4, 629–636
79. Buckley, A.M.; Webber, M.A.; Cooles, S.; Randall, L.P.; La Ragione, R.M.; Woodward, M.J.; Piddock, L.J. The acrab-tolc efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell. Microbiol. 2006, 8, 847–856
80. Nishino, K.; Latifi, T.; Groisman, E.A. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 2006, 59, 126–141
81. Stone, B.J.; Miller, V.L. Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB/c mice. Mol. Microbiol. 1995, 17, 701–712
82. Pérez, A.; Poza, M.; Fernández, A.; Fernández, M.C.; Mallo, S.; Merino, M.; Rumbo-Feal, S.; Cabral, M.P.; Bou, G. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob. Agents Chemother. 2012, 56, 2084–2090
83. Bunikis, I.; Denker, K.; Ostberg, Y.; Andersen, C.; Benz, R.; Bergström, S. An RND-type efflux system in Borrelia burgdorferi is involved in virulence and resistance to antimicrobial compounds. PLoS Pathog. 2008, 4, e1000009
84. Hirakata, Y.; Srikumar, R.; Poole, K.; Gotoh, N.; Suematsu, T.; Kohno, S.; Kamihira, S.; Hancock, R.E.; Speert, D.P. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 2002, 196, 109–118
85. Bina, J.E.; Mekalanos, J.J. Vibrio cholerae tolC is required for bile resistance and colonization. Infect. Immun. 2001, 69, 4681–4685
86. Bengoechea, J.A.; Skurnik, M. Temperature-regulated efflux pump/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia. Mol. Microbiol. 2000, 37, 67–80
87. Shafer, W.M.; Qu, X.; Waring, A.J.; Lehrer, R.I. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 1998, 95, 1829–1833
88. Warner, D.M.; Shafer, W.M.; Jerse, A.E. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol. Microbiol. 2008, 70, 462–478
89. Tzeng, Y.L.; Ambrose, K.D.; Zughaier, S.; Zhou, X.; Miller, Y.K.; Shafer, W.M.; Stephens, D.S. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 2005, 187, 5387–5396
90. Bina, X.R.; Provenzano, D.; Nguyen, N.; Bina, J.E. Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect. Immun. 2008, 76, 3595–3605
91. Chen, Y.C.; Chuang, Y.C.; Chang, C.C.; Jeang, C.L.; Chang, M.C. A K+ uptake protein, TrkA, is required for serum, protamine, and polymyxin B resistance in Vibrio vulnificus. Infect. Immun. 2004, 72, 629–636
92. Kourtesi, C.; Ball, A.R.; Huang, Y.Y.; Jachak, S.M.; Vera, D.M.; Khondkar, P.; Gibbons, S.; Hamblin, M.R.; Tegos, G.P. Microbial efflux systems and inhibitors: Approaches to drug discovery and the challenge of clinical implementation. Open Microbiol. J. 2013, 7, 34–52
93. Zamfir, A.; Seidler, D.G.; Kresse, H.; Peter-Katalinić, J. Structural investigation of chondroitin/ dermatan sulfate oligosaccharides from human skin fibroblast decorin. Glycobiology 2003, 13, 733–742
94. Schmidtchen, A.; Frick, I.M.; Björck, L. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol. 2001, 39, 708–713
95. Bernfield, M.; Götte, M.; Park, P.W.; Reizes, O.; Fitzgerald, M.L.; Lincecum, J.; Zako, M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68, 729–777
96. McBroom, A.J.; Johnson, A.P.; Vemulapalli, S.; Kuehn, M.J. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J. Bacteriol. 2006, 188, 5385–5392
97. Kuehn, M.J.; Kesty, N.C. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 2005, 19, 2645–2655
98. McBroom, A.J.; Kuehn, M.J. Release of outer membrane vesicles by gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 2007, 63, 545–558
99. Duperthuy, M.; Sjöström, A.E.; Sabharwal, D.; Damghani, F.; Uhlin, B.E.; Wai, S.N. Role of the Vibrio cholerae matrix protein Bap1 in cross-resistance to antimicrobial peptides. PLoS Pathog. 2013, 9, e1003620
100. Peschel, A.; Sahl, H.G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 2006, 4, 529–536
101. Schmidtchen, A.; Frick, I.M.; Andersson, E.; Tapper, H.; Björck, L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 2002, 46, 157–168
102. Guina, T.; Yi, E.C.; Wang, H.; Hackett, M.; Miller, S.I. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 2000, 182, 4077–4086
103. Sol, A.; Skvirsky, Y.; Nashef, R.; Zelentsova, K.; Burstyn-Cohen, T.; Blotnick, E.; Muhlrad, A.; Bachrach, G. Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases. J. Biol. Chem. 2014, 289, 22926–22941
104. Selsted, M.E.; Harwig, S.S. Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. J. Biol. Chem. 1989, 264, 4003–4007
105. Maemoto, A.; Qu, X.; Rosengren, K.J.; Tanabe, H.; Henschen-Edman, A.; Craik, D.J.; Ouellette, A.J. Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J. Biol. Chem. 2004, 279, 44188–44196
106. Campopiano, D.J.; Clarke, D.J.; Polfer, N.C.; Barran, P.E.; Langley, R.J.; Govan, J.R.; Maxwell, A.; Dorin, J.R. Structure-activity relationships in defensin dimers: A novel link between beta-defensin tertiary structure and antimicrobial activity. J. Biol. Chem. 2004, 279, 48671–48679
107. Stumpe, S.; Schmid, R.; Stephens, D.L.; Georgiou, G.; Bakker, E.P. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J. Bacteriol. 1998, 180, 4002–4006
108. Biegeleisen, K. The probable structure of the protamine-DNA complex. J. Theor. Biol. 2006, 241, 533–540
109. Kukkonen, M.; Korhonen, T.K. The omptin family of enterobacterial surface proteases/adhesins: From housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int. J. Med. Microbiol. 2004, 294, 7–14
110. Kooi, C.; Sokol, P.A. Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology 2009, 155, 2818–2825
111. Corbett, C.R.; Burtnick, M.N.; Kooi, C.; Woods, D.E.; Sokol, P.A. An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology 2003, 149, 2263–2271
112. Kooi, C.; Subsin, B.; Chen, R.; Pohorelic, B.; Sokol, P.A. Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect. Immun. 2006, 74, 4083–4093
113. Belas, R.; Manos, J.; Suvanasuthi, R. Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 2004, 72, 5159–5167
114. Taggart, C.C.; Greene, C.M.; Smith, S.G.; Levine, R.L.; McCray, P.B.; O’Neill, S.; McElvaney, N.G. Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J. Immunol. 2003, 171, 931–937
115. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389–395
116. Coats, S.R.; To, T.T.; Jain, S.; Braham, P.H.; Darveau, R.P. Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4'-phosphatase, PGN_0524. Int. J. Oral Sci. 2009, 1, 126–135
117. Coats, S.R.; Jones, J.W.; Do, C.T.; Braham, P.H.; Bainbridge, B.W.; To, T.T.; Goodlett, D.R.; Ernst, R.K.; Darveau, R.P. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell Microbiol. 2009, 11, 1587–1599
118. Bishop, R.E. The lipid A palmitoyltransferase PagP: Molecular mechanisms and role in bacterial pathogenesis. Mol. Microbiol. 2005, 57, 900–912
119. Maeshima, N.; Fernandez, R.C. Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front. Cell. Infect. Microbiol. 2013, 3, e3
120. Ernst, R.K.; Yi, E.C.; Guo, L.; Lim, K.B.; Burns, J.L.; Hackett, M.; Miller, S.I. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286, 1561–1565
121. Sampson, T.R.; Saroj, S.D.; Llewellyn, A.C.; Tzeng, Y.L.; Weiss, D.S. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 2013, 497, 254–257
122. Sampson, T.R.; Napier, B.A.; Schroeder, M.R.; Louwen, R.; Zhao, J.; Chin, C.Y.; Ratner, H.K.; Llewellyn, A.C.; Jones, C.L.; Laroui, H.; et al. A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion. Proc. Natl. Acad. Sci. USA 2014, 111, 11163–11168
123. Moranta, D.; Regueiro, V.; March, C.; Llobet, E.; Margareto, J.; Larrarte, E.; Larrate, E.; Garmendia, J.; Bengoechea, J.A. Klebsiella pneumoniae capsule polysaccharide impedes the expression of beta-defensins by airway epithelial cells. Infect. Immun. 2010, 78, 1135–1146
124. Islam, D.; Bandholtz, L.; Nilsson, J.; Wigzell, H.; Christensson, B.; Agerberth, B.; Gudmundsson, G. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 2001, 7, 180–185
125. Sperandio, B.; Regnault, B.; Guo, J.; Zhang, Z.; Stanley, S.L.; Sansonetti, P.J.; Pédron, T. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J. Exp. Med. 2008, 205, 1121–1132
126. Hornef, M.W.; Wick, M.J.; Rhen, M.; Normark, S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat. Immunol. 2002, 3, 1033–1040
127. Napier, B.A.; Burd, E.M.; Satola, S.W.; Cagle, S.M.; Ray, S.M.; McGann, P.; Pohl, J.; Lesho, E.P.; Weiss, D.S. Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. MBio 2013, 4, e00021-13
128. Napier, B.A.; Band, V.; Burd, E.M.; Weiss, D.S. Colistin heteroresistance in Enterobacter cloacae is associated with cross-resistance to the host antimicrobial lysozyme. Antimicrob. Agents Chemother. 2014, 58, 5594–5597
129. Gordon, Y.J.; Romanowski, E.G.; McDermott, A.M. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 2005, 30, 505–515.